
Sanofi India Limited announced its audited financial results for the quarter and financial year ended December 31, 2025.
The company reported revenue from operations of ₹4,198 million for the quarter ended December 31, 2025, compared to ₹4,754 million in the previous quarter and ₹5,149 million in the corresponding quarter last year.
For the full year ended December 31, 2025, revenue from operations stood at ₹18,374 million, as against ₹20,132 million recorded in FY24. Including other income of ₹197 million for FY25, total income for the year reached ₹18,571 million compared to ₹20,297 million in the previous financial year.
Profit for the quarter ended December 31, 2025, came in at ₹617 million, compared to ₹760 million in the September 2025 quarter and ₹913 million in the December 2024 quarter.
On a full-year basis, the company reported a profit of ₹3,267 million for FY25, compared to ₹4,135 million in FY24. While profitability moderated compared to the previous year, the company maintained a stable earnings profile amid evolving market conditions.
The Board has considered and recommended a final dividend of ₹48 per equity share of face value ₹10 each for the financial year ended December 31, 2025, subject to shareholder approval at the upcoming 70th Annual General Meeting.
This final dividend is in addition to the interim dividend of ₹75 per equity share declared on October 29, 2025. With this, the total dividend payout for FY25 amounts to ₹123 per equity share of face value ₹10 each, reflecting the company’s continued commitment to rewarding shareholders.
On February 26, 2026, Sanofi share price opened at ₹4,045.00, down from its previous close of ₹4,134.70. At 9:45 AM, the share price of Sanofi was trading at ₹3,991.60, down by 3.46% on the NSE.
Also Read: Best Long-Term Stocks in Feb 2026!
Sanofi India’s FY25 performance reflects moderated revenues and profits compared to the previous year, while maintaining financial stability. The total dividend of ₹123 per share underscores the company’s strong cash position and consistent shareholder return policy despite a softer earnings year.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 26, 2026, 9:57 AM IST

Nikitha Devi
Nikitha is a content creator with 7+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
